Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in Ukraine has been experiencing steady growth in recent years, driven by a number of factors.
Customer preferences: Customers in Ukraine have shown a growing preference for locally manufactured pharmaceutical products, particularly generics. This is due to the lower cost of these products compared to imported brands, as well as the fact that they are often more readily available.
Trends in the market: One trend that has been observed in the Ukrainian pharmaceuticals market is the increasing focus on research and development. This has led to the development of new and innovative products, which are in high demand among both domestic and international customers. Another trend is the growing popularity of online pharmacies, which offer customers a convenient and cost-effective way to purchase their medications.
Local special circumstances: One of the key factors driving the growth of the pharmaceuticals market in Ukraine is the country's large and aging population. With an increasing number of people requiring medical treatment, demand for pharmaceutical products is expected to continue to rise in the coming years. Additionally, the Ukrainian government has implemented a number of policies aimed at promoting the domestic pharmaceutical industry, including tax incentives and subsidies for local manufacturers.
Underlying macroeconomic factors: The Ukrainian economy has been experiencing steady growth in recent years, driven by a combination of factors including increased foreign investment, rising exports, and a growing domestic consumer market. This has led to increased demand for pharmaceutical products, as more people are able to afford healthcare services and medications. Additionally, the country's strategic location at the crossroads of Europe and Asia has made it an attractive destination for pharmaceutical companies looking to expand their operations into new markets.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)